atherosclerosis
11/29/2017
/
By Jhoanna Robinson
Big Pharma greed strikes again: “Life-changing” thyroid pill manufacturer spikes price by 5,000%
The National Health Service is eyeing the cessation of the incessant prescription of Liothyronine, a drug that is used to treat thyroid disorders, after its manufacturer, Oakville, Canada-based pharmaceutical company Concordia International, increased its retail price by 5,662 percent to 9.22 British pounds from 16 p per tablet. Liothyronine is used to treat hypothyroidism or […]
« Return Home
1 of 1
Popular Articles
COPYRIGHT © 2017 BIG PHARMA NEWS
Privacy Policy